Delivery of tumor treatment fields (TTFELDS) by means of implantable transducer arrays

DE602020044691T2Active Publication Date: 2025-01-08NOVOCURE GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602020044691
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2019-02-27
Filing Date
2020-02-26
Publication Date
2025-01-08
Estimated Expiration
2040-02-26

AI Technical Summary

Technical Problem

The existing TTFields therapy systems, such as Optune, face challenges with skin irritation, limited mobility, and infection risks due to external transducer arrays, and inefficiencies in power delivery and heat management when implanted components are used.

Method used

Implantable transducer arrays with a hub-based architecture and wireless power delivery, along with advanced temperature control mechanisms, reduce the number of conductors through the skin, minimize infection risk, and enhance power efficiency by using high-efficiency AC voltage generators and switchable electrode elements.

Benefits of technology

This approach improves patient comfort, reduces power requirements, minimizes skin irritation, and effectively delivers TTFields to previously inaccessible areas, such as the spinal cord, while maintaining safe tissue temperatures and reducing the risk of infection and thermal damage.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.